Novotech is internationally recognized as a leading regional full-service CRO.
Novotech is Australia’s largest independent CRO. The Australian Head Office is in Sydney, with regional offices in Melbourne and Brisbane - providing easy access to the most important population centers in Australia. Supported by regional staff across the country and in New Zealand, our coverage of the Australia/New Zealand region is comprehensive. With Asian services launched in 2007, Novotech’s operations provide access to the most dynamic and fast growing clinical research hubs in the region.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 19, 2022 | Series Unknown | $255M | — | — | — | Detail |
Jan 19, 2022 | Debt Financing | $505M | — | — | — | Detail |
Dec 1, 2021 | Secondary Market | — | 2 | Sequoia Capital GIC | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 24, 2022
Prospection
|
Corporate Round | — | Analytics | — |
Sep 13, 2021
Prospection
|
Series B | $45M | Analytics | — |
Jun 8, 2021
Obvio Health USA
|
Series B | $19.25M | Health Care | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sequoia Capital | Yes | Secondary Market |
GIC | Yes | Secondary Market |